Recent Articles
Gene Therapy for Hemophilia: Progress and Setbacks
As the FDA delayed the approval of the world’s first gene therapy for hemophilia A, companies forged ahead with phase III trials to gather...
Sequential Pembrolizumab and Chemotherapy Results in Excellent Responses in Newly Diagnosed Classical Hodgkin Lymphoma
A brief course of pembrolizumab monotherapy followed by AVD chemotherapy (doxorubicin, vinblastine, and dacarbazine) was associated with reductions in metabolic tumor volume and prolonged...
Editor’s Corner: Two Ears, One Mouth
I consider myself blessed to come from a medical family. My parents were physicians who were sweethearts in medical school in Egypt. They had...
Emmanuelle Charpentier and Jennifer Doudna Awarded Nobel Prize for CRISPR
The 2020 Nobel Prize in Chemistry was awarded to microbiologist Emmanuelle Charpentier, PhD, and biochemist Jennifer A. Doudna, PhD, for their 2012 discovery of...
California Governor Passes Legislation for State-Sponsored Generic Drugs
California Governor Gavin Newsom recently signed bill SB 852, allowing the creation of a state-sponsored generic drug label, Cal-Rx, through which the state can...
Current Issue
October 2020 Volume 6, Issue 12
This issue examines racism in the U.S. health care system, discusses the FDA's newly loosened blood donation restrictions, and more.